Fresh analysis reveals that individuals who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who end conventional lifestyle programs.
Research printed in a prominent medical journal demonstrates that while overweight people frequently drop about a fifth of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month after stopping.
"Users purchasing these treatments need to be aware of the potential of fast weight regain when the therapy ends," warns expert Dr. Susan Jebb.
That rate of regain suggests a reversion to pre-treatment weight within about one and a half years.
Comparing Therapies
The study, which examined dozens of trials involving thousands of participants, compared the effects of these new drugs with older methods.
Scientists point out that individuals who shed pounds through dieting usually see a less rapid creep back—perhaps 100 grams monthly—post-intervention.
The Reason for the Quick Rebound
Nutrition scientists believe the mechanism of the injections accounts for the amplified weight return.
The injections imitate a body's own chemical called GLP-1, which moderates appetite.
"Long-term administration of the hormone concentrations far above than the body's typical production may cause the body to produce less of its endogenous GLP-1, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication leads to appetite is uncontrolled, making binge eating far more likely."
A Chronic Condition?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals argue that, due to the significant potential of relapse, the treatment might need to be life-long.
This perspective is echoed by drug manufacturers, who state that the findings "highlight the long-term character of obesity," comparing it to managing conditions like high blood pressure.
User Testimonies
Individuals who have come off the jabs describe a powerful return of appetite.
"It felt as if a switch flipping and I was suddenly starving," described one woman.
The struggle is compounded if users have not developed sustainable lifestyle or habit modifications during treatment.
Growing Adoption
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.
- Adoption is more common among females than men.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are effective agents for shedding pounds, they are not a magic cure and maintained weight loss hinges on combined behavioural changes.
